Guardant Health paid its 4 named executives $17.0M in total in FY2023 (Dec).
Pay of each named executive
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
3 years
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
3 years
| FY2021 (Dec) | Not disclosed |
1 year
| FY2021 (Dec) | Not disclosed |
1 year
CEO pay against the pay peers
In FY2025 (Dec), the median CEO pay of the 6 peers with pay on file was $11.7M. CEO pay of Guardant Health for that year is not on file.
- 1Exelixis
- 2Natera
- 3GLAUKOS
- 4Ultragenyx Pharmaceutical
- 5Repligen
- 6Penumbra
- 7Guardant HealthThis companyNot disclosed
- 810x Genomics, Inc.Not disclosed
- 9ACADIA Pharmaceuticals Inc.Not disclosed
- 10Blueprint Medicines CorporationNot disclosed
- 11Exact Sciences CorporationNot disclosed
- 12Lantheus HoldingsNot disclosed
- 13Myriad Genetics, Inc.Not disclosed
- 14NeoGenomics, Inc.Not disclosed
- 15Novocure Ltd.Not disclosed
- 16Twist Bioscience CorporationNot disclosed
- 17Veracyte, Inc.Not disclosed
- 18iRythym Technologies, Inc.Not disclosed
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.